Fiserv to Accelerate Digital Banking Transformation for Clients with Acquisition of Finxact
Finxact digital banking technology to accelerate innovation across the payment and financial services solutions spectrum…
Finxact digital banking technology to accelerate innovation across the payment and financial services solutions spectrum…
SANTA CLARA, Calif.–(BUSINESS WIRE)–#DataStorageTech–Flash Memory Summit (FMS), the world’s premiere flash memory conference and exposition,…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) —…
Lund Sweden, February 7, 2022 – Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the…
STRATEGIC PARTNERSHIP WITH NEXTSTAGE AM The reference shareholders of Eurobio Scientific join forces with NextStage…
Toronto, Ontario–(Newsfile Corp. – February 7, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…
Receives Approval to Treat Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in Phase 1b/2 Trial in…
New Book “Own Your Past, Change Your Future” Available for Presale Feb. 7, 2022 NASHVILLE,…
Third patient treated in the global clinical trial with LYS-GM101 gene therapy program in GM1…
FORT COLLINS, Colo., Feb. 06, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
NEW DELHI, India & CHICAGO–(BUSINESS WIRE)–#coalgasification–Dastur Energy Pvt. Ltd. India (“Dastur”) has entered into an…
SANTA CRUZ, Calif. & SEOUL, South Korea–(BUSINESS WIRE)–SK Telecom (NYSE:SKM, “SKT”), South Korea’s leading telecommunications…
LONDON, SINGAPORE & NEW YORK–(BUSINESS WIRE)–#MonetaGo–Financial technology solutions provider MonetaGo today announced the launch of…
New York, New York–(Newsfile Corp. – February 6, 2022) – Pochi Inu (POCHI) launched on…
Dubai, United Arab Emirates–(Newsfile Corp. – February 5, 2022) – On 1st Feburary, 2022, LBank…
New York, New York–(Newsfile Corp. – February 5, 2022) – The team at Shintama, a…
CAMPBELL, Calif.–(BUSINESS WIRE)–Please replace the release dated January 4, 2022 with the following corrected version…
FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo…
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA,…
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq:…